Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells.

Diabetes & Metabolism
A SoliniF Dotta

Abstract

SGLT2 inhibitors reduce renal glucose uptake through an insulin-independent mechanism. They also increase glucagon concentration, although the extent to which this is due to a direct effect on pancreatic alpha cells remains unclear. In the present work, αTC1 cells treated with the SGLT2 inhibitor dapagliflozin (Dapa) were analyzed for glucose transporters, molecular mediators of hormone secretion, glucagon and GLP-1 release, and the effects of somatostatin. Data were validated in murine and human pancreatic islets. SLC5A2 (the SGLT2-encoding gene) was nearly undetectable in αTC1 cells, not even by a digital PCR technique using different probes. In contrast, SLC5A1 (the SGLT1-encoding gene) was constitutively abundant in αTC1 cells and in islets, and increased with Dapa. This was associated with greater glucagon release, preceded by increased expression of preproglucagon and HNF4α. Looking at the candidate intracellular signalling pathway, reduced PASK and increased AMPK-α2 expression were also detected. GLUT1 and GLUT2, as well as regulators of glucagon release and alpha-cell phenotype (chromogranin A, paired box 6, proprotein convertase 1/2, synaptophysin), were unaffected by Dapa, as were GLP-1 receptor expression and GLP-1 r...Continue Reading

Citations

Aug 10, 2018·Diabetes, Obesity & Metabolism·Clifford J Bailey, Nikolaus Marx
Feb 15, 2019·Diabetes, Obesity & Metabolism·Clifford J Bailey
Apr 4, 2019·American Journal of Physiology. Cell Physiology·Siddharth Sunilkumar, Sue M Ford
Mar 18, 2020·American Journal of Physiology. Endocrinology and Metabolism·Christoffer MartinussenSten Madsbad
Jun 11, 2018·Current Diabetes Reports·Dorrin Zarrin Khat, Mansoor Husain
May 13, 2020·Pflügers Archiv : European journal of physiology·Constantin Berger, Daniela Zdzieblo
Mar 25, 2019·Diabetologia·Rune E KuhreJens J Holst
Oct 15, 2019·Journal of the American Heart Association·Carolyn S P LamSubodh Verma
Mar 2, 2019·Cardiovascular Diabetology·Chiara Maria Assunta CefaloAndrea Giaccari
May 20, 2020·Current Diabetes Reports·Benedetta Maria BonoraGian Paolo Fadini
Aug 17, 2020·The Journal of Biological Chemistry·Rachel J Perry, Gerald I Shulman
Oct 28, 2020·International Journal of Molecular Sciences·Yi-Chou HouKuo-Cheng Lu
Jul 28, 2020·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Yoshifumi SatoKazuya Yamagata
Apr 4, 2021·International Journal of Molecular Sciences·Hideaki KanetoKohei Kaku
Jan 9, 2018·Mayo Clinic Proceedings·Sofie HædersdalTina Vilsbøll
May 7, 2021·European Journal of Pharmacology·Xingyun ZhuLinong Ji
May 13, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jeng Yie ChanD Ross Laybutt
Aug 28, 2021·Cardiovascular Drugs and Therapy·Huan ChenYumei Ye

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.